LIQUORPOND SURGERY
10 LIQUORPOND STREET, BOSTON
HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 22 | 26 | 84.6% | |
| HF 4 | 2011 | 23 | 26 | 88.5% | |
| HF 4 | 2012 | 26 | 28 | 92.9% | |
| HF 4 | 2013 | 22 | 24 | 91.7% | |
| HF004 | 2014 | 7 | 8 | 87.5% | |
| HF004 | 2015 | 6 | 7 | 85.7% | |
| HF004 | 2016 | 7 | 8 | 87.5% | |
| HF004 | 2017 | 12 | 12 | 100.0% | |
| HF004 | 2018 | 15 | 16 | 93.8% | |
| HF004 | 2019 | 17 | 17 | 100.0% | |
| HF004 | 2020 | 15 | 16 | 93.8% | |
| HF006 | 2021 | 21 | 22 | 95.5% | |
| HF006 | 2022 | 55 | 58 | 94.8% | |
| HF006 | 2023 | 68 | 69 | 98.6% |
